• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲苯磺丁脲多晶型物(伯格形式II和IV)的表征及多晶型转变行为

Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.

作者信息

Kimura K, Hirayama F, Uekama K

机构信息

The Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.

出版信息

J Pharm Sci. 1999 Apr;88(4):385-91. doi: 10.1021/js980376z.

DOI:10.1021/js980376z
PMID:10187747
Abstract

Burger's two polymorphs of tolbutamide (TB), an oral hypoglycemic agent, were obtained by spray-drying the drug dissolved in a mixed solvent of ethanol/dichloromethane (Form IV) and allowing Form IV to stand at constant temperatures and humidities (Form II). These polymorphs were characterized by various physical methods [e.g., powder X-ray diffractometry, differential scanning calorimetry, infrared spectrometry, and solid-state carbon-13 nuclear magnetic resonance (13C NMR) spectroscopy] and compared with two other TB polymorphs Forms I and III. The 13C NMR spectra showed that the chemical shift and the peak shape of resonance associated with the toluene and n-butyl moieties of TB were different for each of the four polymorphs, whereas the carbonyl carbon was unchanged, indicating different conformations and molecular motions of the toluene and n-butyl moieties in the solid states. Form IV converted itself to Form II within 3 h when it was stored at 45 degrees C and 75% relative humidity (RH) and, in turn, Form II transformed to Form I at higher temperatures. The conversion of Form IV to Form II proceeded according to a zero-order equation (Polany-Winger equation), and that of Form II to Form I according to a first-order equation. The increase in RH accelerated the polymorphic transition of Form IV. Both the apparent dissolution rate and the solubility of Form IV were nearly identical with those of Form II, because the former changed to the latter during the dissolution, but their dissolution rates and solubility were higher than those of Forms I and III. These dissolution characteristics of TB polymorphs were reflected in the oral absorption behavior in dogs; that is, the bioavailability increased in the order Form I < Form III < Form II approximately Form IV.

摘要

口服降糖药甲苯磺丁脲(TB)的两种多晶型物是通过将溶解在乙醇/二氯甲烷混合溶剂中的药物进行喷雾干燥得到的(晶型IV),并使晶型IV在恒定温度和湿度下放置(晶型II)。这些多晶型物通过各种物理方法进行表征[例如,粉末X射线衍射法、差示扫描量热法、红外光谱法和固态碳-13核磁共振(13C NMR)光谱法],并与另外两种TB多晶型物晶型I和晶型III进行比较。13C NMR光谱表明,对于四种多晶型物中的每一种,与TB的甲苯和正丁基部分相关的共振的化学位移和峰形都不同,而羰基碳不变,这表明固态中甲苯和正丁基部分的构象和分子运动不同。当晶型IV在45℃和75%相对湿度(RH)下储存时,它会在3小时内自行转变为晶型II,反过来,晶型II在更高温度下会转变为晶型I。晶型IV向晶型II的转变按照零级方程(波兰尼-温格方程)进行,晶型II向晶型I 的转变按照一级方程进行。相对湿度的增加加速了晶型IV的多晶型转变。晶型IV的表观溶解速率和溶解度与晶型II几乎相同,因为前者在溶解过程中转变为后者,但它们的溶解速率和溶解度高于晶型I和晶型III。TB多晶型物的这些溶解特性反映在犬的口服吸收行为中;也就是说,生物利用度按晶型I <晶型III <晶型II≈晶型IV的顺序增加。

相似文献

1
Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.甲苯磺丁脲多晶型物(伯格形式II和IV)的表征及多晶型转变行为
J Pharm Sci. 1999 Apr;88(4):385-91. doi: 10.1021/js980376z.
2
Conformational polymorphism of tolbutamide: A structural, spectroscopic, and thermodynamic characterization of Burger's forms I-IV.托比酰胺的构象多态性:布格尔 I-IV 型的结构、光谱和热力学特征。
J Pharm Sci. 2010 Jul;99(7):2975-90. doi: 10.1002/jps.22061.
3
Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.甲苯磺丁脲溶解度的重新评估以及从I型到未知晶型的多晶型转变。
Int J Pharm. 2009 Mar 18;369(1-2):12-8. doi: 10.1016/j.ijpharm.2008.10.018. Epub 2008 Nov 5.
4
Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.采用X射线粉末衍射、差示扫描量热法和衰减全反射傅里叶变换红外光谱法对原料药和片剂制剂中甲磺酸伊马替尼的两种多晶型进行定量测定。
J Pharm Biomed Anal. 2015 Oct 10;114:330-40. doi: 10.1016/j.jpba.2015.06.011. Epub 2015 Jun 12.
5
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.
6
Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.黄连无定形固体分散体与吸收促进剂联合应用通过提高其生物利用度显示出显著的降血糖作用。
Int J Pharm. 2014 Jun 5;467(1-2):50-9. doi: 10.1016/j.ijpharm.2014.03.017. Epub 2014 Mar 5.
7
Crystal forms of tolbutamide from acetonitrile and 1-octanol: effect of solvent, humidity and compression pressure.甲苯磺丁脲在乙腈和1-辛醇中的晶型:溶剂、湿度和压缩压力的影响
Int J Pharm. 2005 Jan 20;288(2):335-48. doi: 10.1016/j.ijpharm.2004.10.006. Epub 2004 Dec 15.
8
Solid state characterization of dehydroepiandrosterone.脱氢表雄酮的固态表征
J Pharm Sci. 1995 Oct;84(10):1169-79. doi: 10.1002/jps.2600841007.
9
Characterization of a novel polymorphic form of celecoxib.塞来昔布一种新型多晶型物的表征
J Pharm Sci. 2006 Feb;95(2):305-17. doi: 10.1002/jps.20522.
10
Thermodynamic Stability Analysis of Tolbutamide Polymorphs and Solubility in Organic Solvents.甲苯磺丁脲多晶型物的热力学稳定性分析及其在有机溶剂中的溶解度
J Pharm Sci. 2016 Jun;105(6):1901-1906. doi: 10.1016/j.xphs.2016.03.021.

引用本文的文献

1
Crystal structure of 4-bromo--(propyl-carbamo-yl)benzene-sulfonamide.4-溴-N-(丙基氨基甲酰基)苯磺酰胺的晶体结构
Acta Crystallogr E Crystallogr Commun. 2022 Apr 7;78(Pt 5):485-489. doi: 10.1107/S2056989022003723. eCollection 2022 May 1.
2
Different BCS Class II Drug-Gelucire Solid Dispersions Prepared by Spray Congealing: Evaluation of Solid State Properties and In Vitro Performances.通过喷雾冷凝法制备的不同BCS II类药物- Gelucire固体分散体:固态性质及体外性能评价
Pharmaceutics. 2020 Jun 12;12(6):548. doi: 10.3390/pharmaceutics12060548.
3
Particle engineering for pulmonary drug delivery.
用于肺部给药的颗粒工程。
Pharm Res. 2007 Mar;24(3):411-37. doi: 10.1007/s11095-006-9174-3.
4
Depth profiling of compression-induced disorders and polymorphic transition on tablet surfaces with grazing incidence X-ray diffraction.利用掠入射X射线衍射对片剂表面压缩诱导的无序和多晶型转变进行深度剖析。
Pharm Res. 2006 Apr;23(4):813-20. doi: 10.1007/s11095-006-9785-8. Epub 2006 Feb 10.
5
Use of glancing angle X-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets.使用掠角X射线粉末衍射法对吲哚美辛和茶碱片剂溶解过程中的深度剖面相变进行研究。
Pharm Res. 2004 Jan;21(1):149-59. doi: 10.1023/b:pham.0000012163.89163.f8.
6
Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions.甲苯磺丁脲、羟丙基-β-环糊精及其分散体的变形行为。
Pharm Res. 2000 Aug;17(8):942-8. doi: 10.1023/a:1007523103979.
7
Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.甲苯磺丁脲与2-羟丙基-α-和-β-环糊精非晶态固体配合物的固态13C核磁共振光谱研究
Pharm Res. 1999 Nov;16(11):1729-34. doi: 10.1023/a:1018958116349.